Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19

BACKGROUND: Neutralizing monoclonal antibodies (MAbs) are a promising therapy for early coronavirus disease 2019 (COVID-19), but their effectiveness has not been confirmed in a real-world setting. METHODS: In this quasi-experimental pre-/postimplementation study, we estimated the effectiveness of MA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Webb, Brandon J, Buckel, Whitney, Vento, Todd, Butler, Allison M, Grisel, Nancy, Brown, Samuel M, Peltan, Ithan D, Spivak, Emily S, Shah, Mark, Sakata, Theadora, Wallin, Anthony, Stenehjem, Eddie, Poulsen, Greg, Bledsoe, Joseph
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Major Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314951/
https://ncbi.nlm.nih.gov/pubmed/34327256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab331
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky